208 related articles for article (PubMed ID: 19382180)
1. Downregulation of connective tissue growth factor by three-dimensional matrix enhances ovarian carcinoma cell invasion.
Barbolina MV; Adley BP; Kelly DL; Shepard J; Fought AJ; Scholtens D; Penzes P; Shea LD; Stack MS
Int J Cancer; 2009 Aug; 125(4):816-25. PubMed ID: 19382180
[TBL] [Abstract][Full Text] [Related]
2. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.
Barbolina MV; Adley BP; Shea LD; Stack MS
Cancer; 2008 Apr; 112(7):1632-41. PubMed ID: 18260155
[TBL] [Abstract][Full Text] [Related]
3. Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone.
Gao YB; Xiang ZL; Zhou LY; Wu ZF; Fan J; Zeng HY; Zeng ZC
J Cancer Res Clin Oncol; 2013 Apr; 139(4):669-79. PubMed ID: 23307318
[TBL] [Abstract][Full Text] [Related]
4. Expression of connective tissue growth factor as a prognostic indicator and its possible involvement in the aggressive properties of epithelial ovarian carcinoma.
Shimbo A; Kajiyama H; Tamauchi S; Yoshikawa N; Ikeda Y; Nishino K; Suzuki S; Niimi K; Sakata J; Kikkawa F
Oncol Rep; 2019 Dec; 42(6):2323-2332. PubMed ID: 31578579
[TBL] [Abstract][Full Text] [Related]
5. Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.
Moran-Jones K; Gloss BS; Murali R; Chang DK; Colvin EK; Jones MD; Yuen S; Howell VM; Brown LM; Wong CW; Spong SM; Scarlett CJ; Hacker NF; Ghosh S; Mok SC; Birrer MJ; Samimi G
Oncotarget; 2015 Dec; 6(42):44551-62. PubMed ID: 26575166
[TBL] [Abstract][Full Text] [Related]
6. Invasion of interstitial matrix by a novel cell line from primary peritoneal carcinosarcoma, and by established ovarian carcinoma cell lines: role of cell-matrix adhesion molecules, proteinases, and E-cadherin expression.
Kokenyesi R; Murray KP; Benshushan A; Huntley ED; Kao MS
Gynecol Oncol; 2003 Apr; 89(1):60-72. PubMed ID: 12694655
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of glypican-3 expression increases migration, invasion, and tumorigenicity of human ovarian cancer cells.
Liu Y; Zheng D; Liu M; Bai J; Zhou X; Gong B; Lü J; Zhang Y; Huang H; Luo W; Huang G
Tumour Biol; 2015 Sep; 36(10):7997-8006. PubMed ID: 25967456
[TBL] [Abstract][Full Text] [Related]
8. Identification of calreticulin as a prognosis marker and angiogenic regulator in human gastric cancer.
Chen CN; Chang CC; Su TE; Hsu WM; Jeng YM; Ho MC; Hsieh FJ; Lee PH; Kuo ML; Lee H; Chang KJ
Ann Surg Oncol; 2009 Feb; 16(2):524-33. PubMed ID: 19050968
[TBL] [Abstract][Full Text] [Related]
9. Modelling genetic and clinical heterogeneity in epithelial ovarian cancers.
Lawrenson K; Sproul D; Grun B; Notaridou M; Benjamin E; Jacobs IJ; Dafou D; Sims AH; Gayther SA
Carcinogenesis; 2011 Oct; 32(10):1540-9. PubMed ID: 21859834
[TBL] [Abstract][Full Text] [Related]
10. Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression.
Barbolina MV; Adley BP; Ariztia EV; Liu Y; Stack MS
J Biol Chem; 2007 Feb; 282(7):4924-4931. PubMed ID: 17158885
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation contributes to frequent inactivation of a putative conditional tumor suppressor gene connective tissue growth factor in ovarian cancer.
Kikuchi R; Tsuda H; Kanai Y; Kasamatsu T; Sengoku K; Hirohashi S; Inazawa J; Imoto I
Cancer Res; 2007 Aug; 67(15):7095-105. PubMed ID: 17671176
[TBL] [Abstract][Full Text] [Related]
12. Identification of integrins alpha6 and beta7 as c-Jun- and transformation-relevant genes in highly invasive fibrosarcoma cells.
Kielosto M; Nummela P; Järvinen K; Yin M; Hölttä E
Int J Cancer; 2009 Sep; 125(5):1065-73. PubMed ID: 19405119
[TBL] [Abstract][Full Text] [Related]
13. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.
Chen PP; Li WJ; Wang Y; Zhao S; Li DY; Feng LY; Shi XL; Koeffler HP; Tong XJ; Xie D
PLoS One; 2007 Jun; 2(6):e534. PubMed ID: 17579708
[TBL] [Abstract][Full Text] [Related]
14. Transmigration of human ovarian adenocarcinoma cells through endothelial extracellular matrix involves alphav integrins and the participation of MMP2.
Leroy-Dudal J; Demeilliers C; Gallet O; Pauthe E; Dutoit S; Agniel R; Gauduchon P; Carreiras F
Int J Cancer; 2005 Apr; 114(4):531-43. PubMed ID: 15609323
[TBL] [Abstract][Full Text] [Related]
15. Activation of NF-kappaB signaling by inhibitor of NF-kappaB kinase beta increases aggressiveness of ovarian cancer.
Hernandez L; Hsu SC; Davidson B; Birrer MJ; Kohn EC; Annunziata CM
Cancer Res; 2010 May; 70(10):4005-14. PubMed ID: 20424119
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab modulates epithelial-to-mesenchymal transition in the retinal pigment epithelial cells via connective tissue growth factor up-regulation.
Chen CL; Liang CM; Chen YH; Tai MC; Lu DW; Chen JT
Acta Ophthalmol; 2012 Aug; 90(5):e389-98. PubMed ID: 22712616
[TBL] [Abstract][Full Text] [Related]
17. Up-Regulation of miR-204 Enhances Anoikis Sensitivity in Epithelial Ovarian Cancer Cell Line Via Brain-Derived Neurotrophic Factor Pathway In Vitro.
Yan H; Wu W; Ge H; Li P; Wang Z
Int J Gynecol Cancer; 2015 Jul; 25(6):944-52. PubMed ID: 25962115
[TBL] [Abstract][Full Text] [Related]
18. Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.
Klymenko Y; Kim O; Loughran E; Yang J; Lombard R; Alber M; Stack MS
Oncogene; 2017 Oct; 36(42):5840-5851. PubMed ID: 28628116
[TBL] [Abstract][Full Text] [Related]
19. Motility-related actinin alpha-4 is associated with advanced and metastatic ovarian carcinoma.
Barbolina MV; Adley BP; Kelly DL; Fought AJ; Scholtens DM; Shea LD; Stack MS
Lab Invest; 2008 Jun; 88(6):602-14. PubMed ID: 18362906
[TBL] [Abstract][Full Text] [Related]
20. Effect of small interfering RNA on the expression of connective tissue growth factor and type I and III collagen in skin fibroblasts of patients with systemic sclerosis.
Xiao R; Liu FY; Luo JY; Yang XJ; Wen HQ; Su YW; Yan KL; Li YP; Liang YS
Br J Dermatol; 2006 Dec; 155(6):1145-53. PubMed ID: 17107381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
